Search research articles
Contact Us
Filters
Showing results (461-470 of 481) with videos related to
Page
of 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Miriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 24, 2013
National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
Kristin Baird, Seth M Steinberg, Lana Grkovic, et al.
BJU International
|
September 24, 2020
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
Ravi A Madan, Fatima H Karzai, Munjid Al Harthy, et al.
Blood Advances
|
April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Adam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2009
Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks
Diane Palmieri, Paul R Lockman, Fancy C Thomas, et al.
The New England Journal of Medicine
|
March 19, 2020
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M Gross, Pamela L Wolters, Eva Dombi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Stephanie L Goff, Mark E Dudley, Deborah E Citrin, et al.
Blood
|
September 15, 2021
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Daniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
John A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
JAMA Oncology
|
September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial
Dickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 481) with videos related to
Sort By:
Page
of 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Miriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 24, 2013
National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
Kristin Baird, Seth M Steinberg, Lana Grkovic, et al.
BJU International
|
September 24, 2020
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
Ravi A Madan, Fatima H Karzai, Munjid Al Harthy, et al.
Blood Advances
|
April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Adam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2009
Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks
Diane Palmieri, Paul R Lockman, Fancy C Thomas, et al.
The New England Journal of Medicine
|
March 19, 2020
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M Gross, Pamela L Wolters, Eva Dombi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Stephanie L Goff, Mark E Dudley, Deborah E Citrin, et al.
Blood
|
September 15, 2021
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Daniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
John A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
JAMA Oncology
|
September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial
Dickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Page
of 49